eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | amyloidosis |
| Symptom | C0027726|nephrotic syndrome |
| Sentences | 14 |
| PubMedID- 21502717 | A long-term remission of renal amyloidosis with nephrotic syndrome after autologous peripheral blood stem-cell transplantation. |
| PubMedID- 23235953 | Rikitake et al., however, reported lambda light chain proteinuria in a 57-year-old female who developed fanconi syndrome and had renal amyloidosis with nephrotic syndrome for the last 5 years . |
| PubMedID- 25984105 | A 46-year-old caucasian female, affected by nephrotic syndrome, was diagnosed with al amyloidosis by renal biopsy (figure 1), performed on the left kidney (maximal longitudinal renal axes 10.9 cm), in december 2006, with an igg-λ as monoclonal protein. |
| PubMedID- 25984151 | We report a patient with sjia and nephrotic syndrome due to aa amyloidosis successfully treated with an anti-interleukin-6 receptor (anti-il-6r) antibody, tocilizumab. |
| PubMedID- 25984052 | But there is no case with nephrotic syndrome due to amyloidosis documented with renal biopsy. |
| PubMedID- 22760913 | In this case, chronic inflammation with abdominal and joint symptoms and nephrotic syndrome due to secondary amyloidosis in an arab patient raised the hypothesis of fmf, even in the setting of quick renal function decline. |
| PubMedID- 24558629 | Here, a case of biopsy-proven renal aa amyloidosis complicated with nephrotic syndrome associated with lung carcinoma is reported. |
| PubMedID- 23472940 | Tocilizumab treatment for nephrotic syndrome due to amyloidosis in behcet's disease. |
| PubMedID- 25572486 | Remission of nephrotic syndrome due to aa-amyloidosis, complicating familiar mediterranean fever, with tocilizumab. |
| PubMedID- 20729743 | Despite this treatment, she developed secondary amyloidosis with nephrotic syndrome 4 years after the initial presentation. |
| PubMedID- 20091495 | We herein report a case of traps complicated with nephrotic syndrome due to aa amyloidosis in which treatment with etanercept was associated with remission of the nephrotic syndrome but no regression of amyloid mass on the follow-up renal biopsy. |
| PubMedID- 25579733 | The patients developed nephrotic syndrome due to secondary amyloidosis, which was refractory to the immunosuppressive agents. |
| PubMedID- 23314147 | Patients are at variable risks for the development of systemic reactive (aa) amyloidosis, leading to the nephrotic syndrome and kidney failure. |
| PubMedID- 24516769 | 4 other manifestations include, recurrent infections, hyperviscosity induced arterial infarctions and venous thrombosis, neurological impairment, nephrotic syndrome, extramedullary involvement of various organs, concomitant amyloidosis with gastrointestinal symptoms, and soft tissue or solitary bone masses (plasmacytomas). |
Page: 1